Results 101 to 110 of about 17,319 (251)

Evaluation of Early Medical Abortion (EMA) pilot sites

, 2008
This DH commissioned research assessed the safety, effectiveness and acceptability of early medical abortions in non-traditional settings, and will contribute towards the establishment of a protocol to cover the elements and processes required for a safe
Lee, Ellie, Lee, Ellie J., Ingham, Roger
core  

Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption

, 2008
BACKGROUND: Studies were carried out to test the hypothesis that administration of a glucocorticoid Type II receptor antagonist, mifepristone (RU38486), just prior to withdrawal from chronic alcohol treatment, would prevent the consequences of the ...
Croft, Adam P., Mulholland, Patrick, Little, Hilary, Prendergast, Mark A., Jacquot, Catherine, Prendergast, Mark A, Croft, Adam P, Shaw, Sidney G, Little, Hilary J., Shaw, Sidney G., Croft, Adam P.; id_orcid, Little, Hilary J   +11 more
core   +1 more source

Mifepristone Antagonization With Progesterone to Prevent Medical Abortion [PDF]

, 2019
ObjectiveTo estimate the efficacy and safety of mifepristone antagonization with high-dose oral progesterone.MethodsWe planned to enroll 40 patients in a double-blind, placebo-controlled, randomized trial.
Dalton, Laura, Hou, Melody Y, Steward, Rachel, Mitchell D. Creinin, Creinin, Mitchell D, Melody Y. Hou, Melissa J. Chen, Chen, Melissa J, Rachel Steward, Laura Dalton   +9 more
core   +1 more source

Use of point‐of‐care ultrasound in the diagnosis of uterine rupture

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 6, Page 868-869, June 2026.
S. Tartaglia, C. Neri, M. A. Policriti, C. Riccetti, A. Familiari, T. Ghi   +5 more
wiley   +1 more source

Mifepristone for uterine fibroids

, 2009
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the eLicacy and safety of Mifepristone in the management uterine fibroids in pre menopausal ...
Spies, J, Leonardo J Orozco, Peter Stone, Orozco, L, Tristan, M, James B Spies, Clarke, JF, Jane Clarke, Mario Tristán, Stone, PR   +9 more
core   +1 more source

Study of effects of mifepristone on full-term pregnancies

, 2020
The induction of labour is required for various indications in obstetrics. Various regimens and drugs are advocated for use in labour induction. Mifepristone is one such drug which has a definite role in first and second-trimester pregnancy terminations.
Uday Bhanu Rana, Priyanka Sharma, Kushla Pathania   +2 more
core   +1 more source

Mifepristone and rapamycin have non-additive benefits for life span in mated female Drosophila

Fly
The drugs mifepristone and rapamycin were compared for their relative ability to increase the life span of mated female Drosophila melanogaster. Titration of rapamycin indicated an optimal concentration of approximately 50 μM, which increased median life
Gary N. Landis, Britta Baybutt, Shoham Das, Yijie Fan, Kate Olsen, Karissa Yan, John Tower   +6 more
doaj   +1 more source

Supplementary Table S8 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

, 2023
Andrés Elía, Leo Saldain, Silvia I. Vanzulli, Luísa A. Helguero, Caroline A. Lamb, Victoria Fabris, Gabriela Pataccini, Paula Martínez‐Vazquez, Javier Burruchaga, Ines Caillet-Bois, Eunice Spengler, Gabriela Acosta Haab, Marcos Liguori, Alejandra Castets, Silvia Lovisi, María F. Abascal, Virginia Novaro, Jana Sánchez, Javier Muñoz, José M. Belizán, Martı́n C. Abba, Hugo Gass, Paola Rojas, Claudia Lanari   +23 more
openalex   +1 more source

Mifepristone: an alternate to dinoprostone in induction of labour

, 2017
Background: To assess and compare the efficacy, safety and fetomaternal outcome of mifepristone versus dinoprostone in priming the cervix and in inducing labour in pregnant women at term.Methods: This is a prospective comparative study done in Chettinad ...
Sailatha R., Famida A. M., K., Vijayalakshmi, Chellaiyan D., Vinoth Gnana, S., Renuka, Vinoth Gnana Chellaiyan D., R., Sailatha, Vijayalakshmi K., Sathiya S., Renuka S., M., Famida A., S., Sathiya   +11 more
core   +1 more source

Role for mifepristone in breast cancer

, 2014
Mifepristone (MFP) is an antiprogestin that has shown some beneficial effects in breast cancer clinical trials. Interestingly, progestins such as medroxyprogesterone acetate (MPA) have also been used as second or third line therapies for breast cancer ...
Molinolo, Alfredo, Sahores, Ana, Lydon, John P., Lamb, Caroline Ana, Lanari, Claudia Lee Malvina   +4 more
core